Home | Events | Going Global – What a Life Sciences Business should consider when expanding internationally or into the UK

Going Global – What a Life Sciences Business should consider when expanding internationally or into the UK

19 January 2023
Member events

Join Freeths' webinar and learn about the challenges facing Life Science businesses.

Date
19 January 2023
Time
16:00 – 17:00
Venue
Online Webinar
View the map
Price
Free of cost

In association with Baker Tilly International and MHA, this webinar, the first in a series of three, aims to tackle some of the challenges faced by Life Sciences businesses when looking to scale up or trade internationally. Our speakers are specialists in the tax, legal and compliance fields and will be able to cut through the complexity of some of the issues faced by business owners in this industry. Some of the topics we will cover are:

· People and resources

· Costs and supply chain disruption

· Dealing with regulation, reporting, compliance, and related costs

· IP protection and management

· Maximising use of technology

· How to deal with ESG

· Navigating variable market access/reimbursement frameworks

· Establishing appropriate scientific evidence generation strategies

  • Speakers

Yogan A. Patel
Partner and Life Sciences Industry Lead at MHA

Yogan will lead the panel discussion.

Chris Denning 
Partner, Corporate and International Tax at MHA
 

Chris will consider some of the broad tax and fiscal matters that need to be considered in light of the challenges businesses will face as they expand across multinational borders. There are direct, indirect and employment tax matters to consider as well as the possibility of accessing beneficial tax reliefs such as R&D tax credits, grants and other fiscal incentives.

Mario Prohasky
Director, Life Sciences Consulting at Baker Tilly US

Mario will discuss some of the key commercial and compliance considerations related to cross-border expansion. In particular, he will focus on the evolving need for effective external stakeholder (HCPs, HEOR experts, Patient, Patient Advocates) engagement as a component of a successful commercial strategy and the associated need for a robust compliance program. 

Claus Andersen 
Partner, Life Sciences, Freeths 

Claus will be adding his legal perspective and will cover and discussing:
The corporate set up, ie. subsidiary, agent, distributor, partnering
IP, identify your IP, register IP and enforce/commercialise/protect IP
Contracts, do they cover your activity? Can they be enforced? Do they need to be adjusted to your expansion?
Regulatory environment, Do you need to apply for prior authorisation? Which areas do you need to adapt to in the new regulatory environment? Promotion? Labelling? Clinical trials? Or other areas?

Freeths is a highly valuable corporate member of the Association. Please visit their company profile.